Sunday, February 2, 2020

Zydus Cadila gets DGCI nod for diabetes treatment drug

Zydus Cadila gets DGCI nod for diabetes treatment drug In India, the drug was previously approved in 2013 for the treatment of hypertriglyceridemia and diabetic dyslipidemia

from Moneycontrol Business News https://ift.tt/2vNlslD

No comments:

Post a Comment

Good news for Indian mutual fund investors: SpaceX could join Nasdaq 100 after 15 trading days

SpaceX’s expected entry into the Nasdaq-100 could give Indian investors indirect exposure through Nasdaq-linked mutual funds. Jefferies says...